Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Immuneering's IMM-1-104 Receives FDA Fast Track Designation for Pancreatic Cancer
Wednesday, February 21, 2024Immuneering Corporation has recently announced that the US Food and Drug Administration granted Fast Track designation for its lead clinicalstage program IMM targeting patients with pancreatic
Cellenkos Receives Approval to Proceed with CK0803 Neurotrophic T Regulatory Cell Therapy for Second Cohort in ALS Trial
Tuesday, February 20, 2024Cellenkos has shared positive safety findings regarding its innovative CK neurotrophic T regulatory cell therapy designed for Amyotrophic Lateral Sclerosis treatment Approval to treat the second patient group in the trial
Jacobio Secures China CDE Clearance for Phase III Clinical Trial of SHP2 Inhibitor and KRAS G12C Inhibitor Combination
Monday, February 19, 2024Jacobio Pharma a clinicalstage oncology company focusing on previously challenging targets has announced the approval of a registrational phase III clinical trial for the combination therapy of its novel KRAS GC inhibitor
Ono Pharmaceuticals and InveniAI Collaborate to Discover New Therapeutic Targets through Research Agreement
Monday, February 19, 2024Ono Pharmaceutical Co Ltd based in Osaka Japan led by President and CEO Gyo Sagara has announced a new research collaboration with InveniAI LLC headquartered in Guilford Connecticut USA
Metoject® Subcutaneous Injection Pen for Methotrexate Receives Regulatory Approval as Autoinjector in Japan
Saturday, February 17, 2024Eisai Co Ltd and nippon medac Co Ltd a subsidiary of medac Gesellschaft fr klinische Spezialprparate mbH jointly announced today that they have received manufacturing and marketing approval from the Japanese Ministry of Health
Astellas Collaborates with Kelonia Therapeutics to Develop Innovative Immuno-Oncology Therapies
Friday, February 16, 2024Astellas Pharma Inc and Kelonia Therapeutics have announced a collaborative effort between Xyphos Biosciences Inc and Kelonia to develop innovative ImmunoOncology therapeutics
Pressure BioSciences Completes Move to New Manufacturing Facility, Uniting R&D with Expanded UltraShear Equipment Development and Contract Manufacturing
Friday, February 16, 2024Pressure BioSciences Inc celebrated a significant milestone today by consolidating its Boston area operations into a cuttingedge facility in Canton MA This move brings together all personnel under
Carrick Therapeutics Initiates Phase 1b/2 Clinical Trial Treating Advanced Breast Cancer Patients with Samuraciclib in Combination with Vepdegestrant: First Patient Dosed
Thursday, February 15, 2024Carrick Therapeutics a company specializing in oncology treatments has announced the initiation of its Phase b clinical trial marking the dosing of the first patient This trial aims to evaluate the combination of samuraciclib
University Forms Research Partnership in Precision Medicine with Bruker
Wednesday, February 14, 2024The University of Sydney is set to lead the charge in global advancements in nanomedicine gene therapies and disease detection treatment and prevention through a strategic partnership This collaboration aims to place the university at the forefront o...
CAN-3110 Granted FDA Fast Track Status for Treating Recurrent High-Grade Glioma
Wednesday, February 14, 2024Candel Therapeutics Inc listed on Nasdaq under CADL a clinicalstage biopharmaceutical company focusing on developing innovative multimodal biological immunotherapies for cancer treatment
